乳腺癌筛查的新方法
本文综述了乳腺癌筛查领域的新技术,包括数字乳腺断层合成、对比增强能谱乳腺X线摄影、超声(自动三维乳腺超声、透射断层成像、弹性成像、光声成像)、MRI(简化与超快速、扩散加权成像)及分子乳腺成像,并讨论了人工智能与放射组学的潜在作用,以及液体活检和呼气试验等非影像学筛查方法可能改变筛查格局。
要点
- 当前筛查方法敏感度有限且假阳性率高,新影像技术可能很快参与乳腺癌筛查。
- 数字乳腺断层合成、对比增强能谱乳腺X线摄影、超声新技术、MRI新技术及分子乳腺成像均为候选新方法。
- 人工智能与放射组学有潜力进一步改进筛查策略,液体活检和呼气试验等非影像学检查可能改变筛查格局。
核心结论
- 乳腺癌筛查可降低乳腺癌相关死亡率,且早期发现有助于采用更温和的治疗。
- 当前筛查方法不完美,敏感度有限且假阳性率高;多种乳腺影像新技术可能很快在筛查中发挥作用。
- 人工智能与放射组学有潜力进一步改进筛查策略;液体活检和呼气试验等非影像学筛查检查可能改变筛查格局。
研究设计与样本
- 本文为综述,检索范围与纳入文献原文未报告。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Screening for breast cancer reduces breast cancer-related mortality and earlier detection facilitates less aggressive treatment. Unfortunately, current screening modalities are imperfect, suffering from limited sensitivity and high false-positive rates. Novel techniques in the field of breast imaging may soon play a role in breast cancer screening: digital breast tomosynthesis, contrast material-enhanced spectral mammography, US (automated three-dimensional breast US, transmission tomography, elastography, optoacoustic imaging), MRI (abbreviated and ultrafast, diffusion-weighted imaging), and molecular breast imaging. Artificial intelligence and radiomics have the potential to further improve screening strategies. Furthermore, nonimaging-based screening tests such as liquid biopsy and breathing tests may transform the screening landscape. © RSNA, 2020 Online supplemental material is available for this article.
引用
- Mann RM, Hooley R, Barr RG, et al. Novel Approaches to Screening for Breast Cancer. Radiology. 2020. PMID: 32897163. doi:10.1148/radiol.2020200172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。